News
EquiSeq Featured in Albuquerque Journal
ALBUQUERQUE, NEW MEXICO – January 11, 2026

EquiSeq was profiled in the Business section of the Albuquerque Journal on January 11, 2026. The article, by writer Hannah Garcia, described the company’s origins and the road ahead, based on interviews with Paul Szauter, Chief Scientific Officer; Madison Sanders, an equestrian who is a member of EquiSeq’s Board of Directors; and Jeremy Edwards, a scientist at the University of New Mexico. Coverage was prompted by the issuance of a second U.S. patent for DNA testing of horses to detect the predisposition to muscle disease.
Please see the full article in the Albuquerque Journal.
Share this post
From the blog
The latest industry news, interviews, technologies, and resources.
A Drug for PSSM?
INTRODUCTION A new drug that inhibits glycogen synthase I, encoded by GYS1, reduces…
EquiSeq Featured in Albuquerque Journal
ALBUQUERQUE, NEW MEXICO – January 11, 2026 EquiSeq was profiled in the Business…
